Angiotensin-converting enzyme gene polymorphism and carotid wall thickening in a community population

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 8, 1999, Pages 1969-1974

  Hung, Joseph ^b,c   McQuillan, Brendan M ^a   Nidorf, Mark ^a   Thompson, Peter L ^a   Beilby, John P ^b  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Angiotensin converting enzyme; Atherosclerosis; Genes; Intima medial thickness; Ultrasonography

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; B SCAN; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

EID: 0032807534     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.8.1969     Document Type: Article

References (30)

1. Cambien F, Poirer O, Lecerf L, Evans A, Cambou J-P, Arveiler D, Luc G, Bard J-M, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
2. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation. 1996; 94:708-712.
3. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995;332:706-711.
4. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992;51:197-205.
5. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
6. Danser AHJ, Schalekamp MADH, Bax WA, van den Brink AM, Saxena PR, Riegger GAJ, Schunkert H. Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation. 1995;92:1387-1388.
7. Daeman MJAP, Lanbardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and rat arterial wall. Circ Res. 1991;68:450-456.
8. Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, Saruta T. Angiotensin 2 stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens. 1991;9:17-21.
9. Powell SJ, Clozel JP, Muller RKM. Inhibitors of angiotensin-converting enzyme myointimal proliferation after vascular injury. Science. 1989;245: 186-188.
10. Farhy RD, Ho KL, Carretero OA, Scicli AG. Kinins mediate the antiproliferative effects of ramipril in rat carotid artery. Biochem Biophys Res Commun. 1992;182:283-288.
11. Castellano M, Muiesan ML, Rizzoni D, Beschi M, Pasini G, Cinelli A, Salvetti M., Porteri E, Bettoni G, Kreutz R, Lindpaintner K, Rosei EA. Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population: the Vobarno study. Circulation. 1995; 91:2721-2724.
12. Dessi-Fulgheri P, Catalini R, Sarzani R, Sturbmi S, Siragusa N, Guazzarotti F, Offidani M, Tamburrini P, Zingaretti O, Rappelli A. Angiotensin converting enzyme gene polymorphism and carotid atherosclerosis in a low-risk population. J Hypertens. 1995;13:1593-1596.
13. Markus HS, Barley J, Lunt R, Bland JM, Jeffery S, Carter ND, Brown MM. Angiotensin-converting enzyme gene deletion polymorphism: a new risk factor for lacunar stroke but not carotid atheroma. Stroke. 1995;26:1329-1333.
14. Hosoi M, Nishizawa Y, Kogawa K, Kawagishi T, Konishi T, Maekawa K, Emoto M, Fukumoto S, Shioi A, Shoji T, Inaba M, Okuno Y, Morii H. Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin-dependent diabetic patients. Circulation. 1996;94:704-707.
15. Pujia A, Motti C, Irace C, Cortese C, Biagiotti L, Mattioli PL, Federici G, Gnasso A. Deletion polymorphism in angiotensin converting enzyme gene associated with carotid wall thickening in a healthy male population. Coron Artery Dis. 1996;7:51-55.
16. Kauma H, Päivänsalo M, Savolainen MJ, Rantala AO, Kiema TR, Lilja M, Reunanen A, Kesäniemi YA. Association between angiotensin converting enzyme gene polymorphism and carotid atherosclerosis. J Hypertens. 1996;14:1183-1187.
17. Risk Factor Prevalence Study Management Committee. Risk Factor Prevalence Study: Survey No. 3, 1989. Canberra, New South Wales: National Heart Foundation of Australia and Australian Institute of Health; 1990:141.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
19. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/ deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992; 20:1433.
20. Shanmugan V, Sell KW, Bratin KS. Mistyping ACE heterozygotes. PCR Methods Appl. 1993;3:120-121.
21. Harjanne A. Automated kinetic determination of angiotensin-converting enzyme in serum. Clin Chem. 1984;30:901-902.
22. Buttery JE, Gee D. Millimolar absorptivity of FAPGG. Clin Chem. 1992;38:1505-1506.
23. Salonen R, Haapanen A, Salonen JT. Measurement of intima-media thickness of common carotid arteries with high-resolution B-mode ultra-sonography: inter- and intra-observer variably. Ultrasound Med Biol. 1991;17:225-230.
24. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399-1406.
25. Adams MR, Nakagomi A, Keech A, Robinson J, McCredie R, Bailey BP, Freedman SB, Celermajer DS. Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation. 1995;92:2127-2134.
26. Kannel WB, Wolf PA. Putting it all together: changing the cardiovascular outlook. Am Heart J. 1992;123:264-267.
27. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation. 1993;87(suppl II):II-56-II-65.
28. Lonn EM, Yusuf S, Jha P, Montague TJ, Teo KK, Benedict CR, Pitt B. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation. 1994;90:2056-2069.
29. Mancini GBJ, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, Wargovich TJ, Mudra H, Luscher TF, Klibaner MI, Haber HE, Uprichard ACG, Pepine CJ, Pitt B. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND study (Trial on Reversing ENdothelial Dysfunction). Circulation. 1996;94:258-265.
30. Singer DRJ, Missouris CG, Jeffrey S. Angiotensin-converting enzyme gene polymorphism: what to do about all the confusion? Circulation. 1996;94:236-239.